Growth Metrics

Collegium Pharmaceutical (COLL) Finished Goods (2016 - 2025)

Collegium Pharmaceutical has reported Finished Goods over the past 10 years, most recently at $20.2 million for Q3 2025.

  • For Q3 2025, Finished Goods rose 23.13% year-over-year to $20.2 million; the TTM value through Sep 2025 reached $20.2 million, up 23.13%, while the annual FY2024 figure was $17.8 million, 17.12% up from the prior year.
  • Finished Goods for Q3 2025 was $20.2 million at Collegium Pharmaceutical, roughly flat from $20.2 million in the prior quarter.
  • Over five years, Finished Goods peaked at $36.9 million in Q1 2022 and troughed at $9.5 million in Q2 2021.
  • A 5-year average of $16.5 million and a median of $15.2 million in 2023 define the central range for Finished Goods.
  • Biggest five-year swings in Finished Goods: soared 280.78% in 2022 and later crashed 62.81% in 2023.
  • Year by year, Finished Goods stood at $12.7 million in 2021, then increased by 27.77% to $16.2 million in 2022, then dropped by 6.29% to $15.2 million in 2023, then rose by 17.12% to $17.8 million in 2024, then grew by 13.64% to $20.2 million in 2025.
  • Business Quant data shows Finished Goods for COLL at $20.2 million in Q3 2025, $20.2 million in Q2 2025, and $18.5 million in Q1 2025.